Effect of EITC on Biological Markers of Aging, Health and Mortality (PaycheckPlus)

April 4, 2022 updated by: Columbia University

An Experimental Investigation Into the Impact of Socioeconomic Context on Biological Markers of Aging, Health and Mortality

Paycheck Plus (PP) is a randomized controlled experiment (RCT) that explores the health and longevity effects associated with increasing the Earned Income Tax Credit (EITC). EITC is a national program that provides tax credits to low-income, disproportionately minority workers who file taxes. EITC is politically popular, having received bipartisan support. The EITC, along with state supplemental programs, have 7 million American families out of poverty. The investigators' preliminary data analyses show that the EITC has had large population health impacts, reversing declines in self rated health and survival among the poorest Americans.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Poverty disproportionately impacts minority and rural populations and is very strongly correlated with poor health over the life cycle, and has been hypothesized to lead to a shorter, less healthy aging process. Poverty is associated with a greater burden of disease than smoking and obesity combined and accounts for the bulk of health disparities by race. It is widely believed that an antipoverty policy, such as Earned Income Tax Credit (EITC), could improve healthy aging among working-age low-income adults over the life cycle. It does so by increasing material hardship and psychological stress, two risk factors that are strongly correlated with biological markers of premature aging (e.g., shorter telomeres, higher cholesterol levels, and higher blood pressure).

Study Type

Interventional

Enrollment (Actual)

1350

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30303
        • Westat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. a US resident
  2. Filed taxes
  3. Earned <$30,000 in the previous year
  4. Aged 21-64
  5. Have a Social Security number

Exclusion Criteria:

  1. Eligible for Supplemental Security Income or Social Security Disability Insurance
  2. Married
  3. Have dependent children

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
Paycheck Plus: Participants will receive four times the standard Earned Income Tax Credit after filing their annual taxes
A four-fold increase in the Earned Income Tax Credit
No Intervention: Control
Control participants will receive the standard Earned Income Tax Credit after filing their annual taxes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Score on the Patient Health Questionnaire-9 (PHQ-9)
Time Frame: 4 Years
Depression will be measured using the subject's score on the PHQ-9.
4 Years
EuroQol 5D5L
Time Frame: 4 years
Health-related quality of life
4 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Body Mass Index (BMI)
Time Frame: 2 Years
A measure of obesity
2 Years
Telomere length
Time Frame: 4 years
Telomere length is a measure of biological age
4 years
Mortality
Time Frame: 4 years
We will link records to National Death Index for future study
4 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter Muennig, MD, Columbia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2016

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

July 18, 2017

First Submitted That Met QC Criteria

July 20, 2017

First Posted (Actual)

July 21, 2017

Study Record Updates

Last Update Posted (Actual)

April 6, 2022

Last Update Submitted That Met QC Criteria

April 4, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • AAAQ9663 (ADD-ON)
  • R01AG054466 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

To protect participant privacy we cannot share our data

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Poverty

Clinical Trials on Paycheck Plus

3
Subscribe